Metronidazole delivery nanosystem able to reduce the pathogenicity of bacteria in colorectal infection

Ana Oliveira; Ana Araújo; Luísa C. Rodrigues; Catarina S. Silva; Rui L. Reis; Nuno M. Neves; Pedro Leão; Albino Martins

doi:10.1021/acs.biomac.2c00186

Metronidazole delivery nanosystem able to reduce the pathogenicity of bacteria in colorectal infection

Ana Oliveira, Ana Araújo, Luísa C. Rodrigues, Catarina S. Silva, Rui L. Reis, Nuno M. Neves, Pedro Leão, Albino Martins^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Abstract

Metronidazole (MTZ) is a drug potentially used for the treatment of intestinal infections, namely, the ones caused by colorectal surgery. The traditional routes of administration decrease its local effectiveness and present off-site effects. To circumvent such limitations, herein a drug delivery system (DDS) based on MTZ-loaded nanoparticles (NPs) immobilized at the surface of electrospun fibrous meshes is proposed. MTZ at different concentrations (1, 2, 5, and 10 mg mL-1) was loaded into chitosan-sodium tripolyphosphate NPs. The MTZ loaded into NPs at the highest concentration showed a quick release in the first 12 h, followed by a gradual release. This DDS was not toxic to human colonic cells. When tested against different bacterial strains, a significant reduction of Escherichia coli and Staphylococcus aureus was observed, but no effect was found against Enterococcus faecalis. Therefore, this DDS offers high potential to locally prevent the occurrence of infections after colorectal anastomosis.

Original language	English
Pages (from-to)	2415-2427
Number of pages	13
Journal	Biomacromolecules
Volume	23
Issue number	6
DOIs	https://doi.org/10.1021/acs.biomac.2c00186
Publication status	Published - 13 Jun 2022
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1021/acs.biomac.2c00186Licence: CC BY

Cite this

@article{76f44b519355493f8a2ed7440c3ef984,

title = "Metronidazole delivery nanosystem able to reduce the pathogenicity of bacteria in colorectal infection",

abstract = "Metronidazole (MTZ) is a drug potentially used for the treatment of intestinal infections, namely, the ones caused by colorectal surgery. The traditional routes of administration decrease its local effectiveness and present off-site effects. To circumvent such limitations, herein a drug delivery system (DDS) based on MTZ-loaded nanoparticles (NPs) immobilized at the surface of electrospun fibrous meshes is proposed. MTZ at different concentrations (1, 2, 5, and 10 mg mL-1) was loaded into chitosan-sodium tripolyphosphate NPs. The MTZ loaded into NPs at the highest concentration showed a quick release in the first 12 h, followed by a gradual release. This DDS was not toxic to human colonic cells. When tested against different bacterial strains, a significant reduction of Escherichia coli and Staphylococcus aureus was observed, but no effect was found against Enterococcus faecalis. Therefore, this DDS offers high potential to locally prevent the occurrence of infections after colorectal anastomosis.",

author = "Ana Oliveira and Ana Ara{\'u}jo and Rodrigues, {Lu{\'i}sa C.} and Silva, {Catarina S.} and Reis, {Rui L.} and Neves, {Nuno M.} and Pedro Le{\~a}o and Albino Martins",

note = "Funding Information: The authors thank the Portuguese Foundation for Science and Technology (FCT) and CUF, S.A. for the Ph.D. scholarship of A.O. (PD/BDE/142979/2018). Also, the authors thank the FCT for the financial support of L.C.R. (SFRH/BPD/93697/2013). This work was also financially supported by the project Bluebiolab – Transboundary Marine Biotechnology Laboratory (0474_BLUEBIOLAB_1_E) financed by the Interreg programme Spain-Portugal through the European Regional Development Fund (ERDF), and by the FCT projects PTDC/CTM-CTM/29813/2017-(POCI-01-0145-FEDER-029813), UIDB/50026/2020, and UIDP/50026/2020. Publisher Copyright: {\textcopyright} 2022 American Chemical Society.",

year = "2022",

month = jun,

day = "13",

doi = "10.1021/acs.biomac.2c00186",

language = "English",

volume = "23",

pages = "2415--2427",

journal = "Biomacromolecules",

issn = "1525-7797",

publisher = "American Chemical Society",

number = "6",

}

TY - JOUR

T1 - Metronidazole delivery nanosystem able to reduce the pathogenicity of bacteria in colorectal infection

AU - Oliveira, Ana

AU - Araújo, Ana

AU - Rodrigues, Luísa C.

AU - Silva, Catarina S.

AU - Reis, Rui L.

AU - Neves, Nuno M.

AU - Leão, Pedro

AU - Martins, Albino

N1 - Funding Information: The authors thank the Portuguese Foundation for Science and Technology (FCT) and CUF, S.A. for the Ph.D. scholarship of A.O. (PD/BDE/142979/2018). Also, the authors thank the FCT for the financial support of L.C.R. (SFRH/BPD/93697/2013). This work was also financially supported by the project Bluebiolab – Transboundary Marine Biotechnology Laboratory (0474_BLUEBIOLAB_1_E) financed by the Interreg programme Spain-Portugal through the European Regional Development Fund (ERDF), and by the FCT projects PTDC/CTM-CTM/29813/2017-(POCI-01-0145-FEDER-029813), UIDB/50026/2020, and UIDP/50026/2020. Publisher Copyright: © 2022 American Chemical Society.

PY - 2022/6/13

Y1 - 2022/6/13

N2 - Metronidazole (MTZ) is a drug potentially used for the treatment of intestinal infections, namely, the ones caused by colorectal surgery. The traditional routes of administration decrease its local effectiveness and present off-site effects. To circumvent such limitations, herein a drug delivery system (DDS) based on MTZ-loaded nanoparticles (NPs) immobilized at the surface of electrospun fibrous meshes is proposed. MTZ at different concentrations (1, 2, 5, and 10 mg mL-1) was loaded into chitosan-sodium tripolyphosphate NPs. The MTZ loaded into NPs at the highest concentration showed a quick release in the first 12 h, followed by a gradual release. This DDS was not toxic to human colonic cells. When tested against different bacterial strains, a significant reduction of Escherichia coli and Staphylococcus aureus was observed, but no effect was found against Enterococcus faecalis. Therefore, this DDS offers high potential to locally prevent the occurrence of infections after colorectal anastomosis.

AB - Metronidazole (MTZ) is a drug potentially used for the treatment of intestinal infections, namely, the ones caused by colorectal surgery. The traditional routes of administration decrease its local effectiveness and present off-site effects. To circumvent such limitations, herein a drug delivery system (DDS) based on MTZ-loaded nanoparticles (NPs) immobilized at the surface of electrospun fibrous meshes is proposed. MTZ at different concentrations (1, 2, 5, and 10 mg mL-1) was loaded into chitosan-sodium tripolyphosphate NPs. The MTZ loaded into NPs at the highest concentration showed a quick release in the first 12 h, followed by a gradual release. This DDS was not toxic to human colonic cells. When tested against different bacterial strains, a significant reduction of Escherichia coli and Staphylococcus aureus was observed, but no effect was found against Enterococcus faecalis. Therefore, this DDS offers high potential to locally prevent the occurrence of infections after colorectal anastomosis.

UR - http://www.scopus.com/inward/record.url?scp=85131684054&partnerID=8YFLogxK

U2 - 10.1021/acs.biomac.2c00186

DO - 10.1021/acs.biomac.2c00186

M3 - Article

C2 - 35623028

AN - SCOPUS:85131684054

SN - 1525-7797

VL - 23

SP - 2415

EP - 2427

JO - Biomacromolecules

JF - Biomacromolecules

IS - 6

ER -

Metronidazole delivery nanosystem able to reduce the pathogenicity of bacteria in colorectal infection

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this